Veradigm | MDRX - Stammkapital





Stammkapital Veränderung Datum
Alcidion AUD 1.34B 0 2025-12
Ambu A/S DKK 266.39M 165.6K 2026-03
Amplifon EUR 219.94M 0 2025-12
Cardinal Health USD 235M 1000K 2026-03
Centene USD 493.77M 2.01M 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cigna USD 264.6M 1.14M 2026-03
Coloplast 225.37M 0 2025-12
Computer Programs Systems USD 14.99M 14.97M 2025-12
Convatec Group USD 251.5M 0 2024-12
CVS Health USD 1.27B 2M 2026-03
Elevance Health USD 217.37M 4.87M 2026-03
General Electric Aerospace USD 1.04B 5.43M 2026-03
Gulf Medical Proj AED 698.92M 0 2025-12
Humana USD 120.06M 529K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Maximus USD 53.11M 563.2M 2026-03
McKesson USD 280M 156M 2025-12
Med Life RON 530.82M 0 2025-12
Molina Healthcare USD 52M 1000K 2026-03
Omnicell USD 45.48M 600K 2026-03
Oriola-kd EUR 185.24M 0 2025-12
Owens Minor USD 76.39M 911K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Rede D'or Sao Luiz BRL 2.2B 7.2M 2026-03
Siemens Healthineers EUR 1.12B 2.36M 2026-03
Sonova Holding CHF 59.61M 10.56K 2025-06
Supermax Corporation Bhd MYR 3.06B 0 2025-12
UnitedHealth USD 907.68M 1.84M 2026-03
Veeva Systems USD 164.38M 39K 2025-12
Veradigm USD 106.07M 103.28M 2022-12
Xerox USD 126M 2M 2025-03